Latest News & Updates
Breaking News
9 minutes ago
Simantini Singh Deo
Other trending news you may like to read
Belite Bio Reports Positive Topline Results From Global Phase 3 DRAGON Trial Of Tinlarebant, Achieving First Successful Pivotal Study In Stargardt Disease Type 1
Belite Bio’s Tinlarebant succeeds in the Phase 3 DRAGON trial, showing a 36% reduction in STGD1 lesion growth and marking a potential first treatment.
Simantini Singh Deo
Biodexa Pharmaceuticals Begins European Enrollment In Phase 3 Serenta Trial As University Of Bonn Registers First Three Patients For eRapa In Familial Adenomatous Polyposis
Biodexa begins European enrollment in its Phase 3 Serenta trial of eRapa for FAP, advancing a potential non-surgical treatment option.
Simantini Singh Deo
Cullinan Therapeutics Receives FDA Fast Track For CLN-049 To Treat Relapsed Or Refractory AML; Phase 1 Data To Be Presented At 67th ASH Annual Meeting
FDA grants Fast Track status to Cullinan’s CLN-049 for relapsed AML, with early Phase 1 data to be presented at ASH 2025.
Simantini Singh Deo
Mapi Pharma Begins Search For New Partners To Advance Long-Acting Depot Peptide Drugs Designed For Easy Self-Administration
Mapi Pharma to present partnering opportunities at the Evercore Healthcare Conference, highlighting its long-acting depot pipeline and new clinical programs.
Simantini Singh Deo
